Graphite Bio Performance
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Graphite Bio are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Graphite Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Graphite Bio is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
Graphite |
Graphite Bio Relative Risk vs. Return Landscape
If you would invest (100.00) in Graphite Bio on September 27, 2025 and sell it today you would earn a total of 100.00 from holding Graphite Bio or generate -100.0% return on investment over 90 days. Graphite Bio is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Graphite, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Graphite Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Graphite Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Graphite Bio, and traders can use it to determine the average amount a Graphite Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| GRPH |
Based on monthly moving average Graphite Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Graphite Bio by adding Graphite Bio to a well-diversified portfolio.
Graphite Bio Fundamentals Growth
Graphite Stock prices reflect investors' perceptions of the future prospects and financial health of Graphite Bio, and Graphite Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Graphite Stock performance.
| Return On Equity | -0.52 | |||
| Return On Asset | -0.18 | |||
| Current Valuation | 1.88 M | |||
| Shares Outstanding | 58.24 M | |||
| Price To Earning | 0.70 X | |||
| Price To Book | 1.01 X | |||
| EBITDA | (70.7 M) | |||
| Cash And Equivalents | 322.29 M | |||
| Cash Per Share | 5.54 X | |||
| Total Debt | 362 K | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | 3.17 X | |||
| Cash Flow From Operations | (90.01 M) | |||
| Earnings Per Share | (2.19) X | |||
| Total Asset | 188.46 M | |||
| Retained Earnings | (367.05 M) | |||
| Current Asset | 8 K | |||
| Current Liabilities | 451 K | |||
Things to note about Graphite Bio performance evaluation
Checking the ongoing alerts about Graphite Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Graphite Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Graphite Bio is not yet fully synchronised with the market data | |
| Graphite Bio has some characteristics of a very speculative penny stock | |
| Graphite Bio has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (124.65 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Graphite Bio currently holds about 322.29 M in cash with (90.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.54. | |
| Over 84.0% of the company shares are owned by institutional investors |
- Analyzing Graphite Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Graphite Bio's stock is overvalued or undervalued compared to its peers.
- Examining Graphite Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Graphite Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Graphite Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Graphite Bio's stock. These opinions can provide insight into Graphite Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Graphite Stock
If you are still planning to invest in Graphite Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Graphite Bio's history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |